KR890009923A - 헤테로사이클릭 화합물 - Google Patents

헤테로사이클릭 화합물 Download PDF

Info

Publication number
KR890009923A
KR890009923A KR1019880017218A KR880017218A KR890009923A KR 890009923 A KR890009923 A KR 890009923A KR 1019880017218 A KR1019880017218 A KR 1019880017218A KR 880017218 A KR880017218 A KR 880017218A KR 890009923 A KR890009923 A KR 890009923A
Authority
KR
South Korea
Prior art keywords
azabicyclo
octan
amino
alkyl
carbonyl
Prior art date
Application number
KR1019880017218A
Other languages
English (en)
Other versions
KR970009588B1 (ko
Inventor
제임스 워드 테렌스
크리스틴 화이트 자네트
Original Assignee
폴 에이 리쳐
존 와이어스 앤드 브라더 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878730193A external-priority patent/GB8730193D0/en
Priority claimed from GB888819728A external-priority patent/GB8819728D0/en
Application filed by 폴 에이 리쳐, 존 와이어스 앤드 브라더 리미티드 filed Critical 폴 에이 리쳐
Publication of KR890009923A publication Critical patent/KR890009923A/ko
Application granted granted Critical
Publication of KR970009588B1 publication Critical patent/KR970009588B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/04—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • C07D453/04—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems having a quinolyl-4, a substituted quinolyl-4 or a alkylenedioxy-quinolyl-4 radical linked through only one carbon atom, attached in position 2, e.g. quinine

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Otolaryngology (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

내용 없음

Description

헤테로사이클릭 화합물
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (12)

  1. 일반식(Ⅰ)의 헤테로사이클릭 화합물 또는 약제학적 허용되는 이의 산부가염.
    A-X-NHCW-Y-B (Ⅰ)
    상기식에서 A는
    의 방향족 라디칼 [여기에서, 자유 원자가는 일반식(a)의 융합 환 또는 일반식(b)의 융합환에 결합된다]이고, R1은 수소, 또는 저급알킬, 저급알콕시, 하이드록시, 할로겐, 할로(저급알킬), 아미노, 니트로, 카복스, 아미도, 페닐(저급)알킬옥시(여기에서 페닐그룹은 임의로 하나 이상의 저급알킬, 저급알킬옥시 또는 할로치환체에 의해 치환될 수 있다), (저급)알킬아미노, 디(저급)알킬아미노, 디(저급)알킬아미노 및 아실아미노중에서 선택된 하나 이상의 동일하거나 상이한 치환체이고, Z1및 Z2는 CH2-CH, NR2-CH, O-CH, S-CH, CH2-N, O-N, S-N, NR2-N, CH-NR2또는 N-NR2[여기에서 R2는 수소, (저급)알킬, 또는 페닐 또는 페닐 (저급)알킬(여기에서 페닐그룹은 하나 이상의 저급알킬, 저급알킬옥시 또는 할로치환체에 의해 임의로 치환될 수 있다)]이고, Z3및 Z4는 CH=CH, O-CH2또는 N=CH이고, Z5는 N 또는 CH이고, Z6는 O, S 또는 NH이고, X는 직접결합이거나, CO이고, W는 산소 또는 황이고, Y는 NH 또는 산소이고, B는 일반식
    의 포화 아자사이클릭 환이고, 여기에서 n은 2,3 또는 4이고, m은 1,2 또는 3이고, p는 0,1 또는 2이고, R3은 수소, 또는 (저급)알킬이고, R4및 R5는 각각 수소 또는 저급알킬이며 단, X가 직접결합일 경우, A는 일반식(c) 또는 (d)의 그룹이고 W는 산소이며, 환(c) 또는 (d)는 -X-NHCW-Y-B 측쇄에 대해 오르토 위치에 치환체를 함유하지 않는다.
  2. 제1항에 있어서, X가 CO인 화합물.
  3. 제1항에 있어서, A가 일반식()인 화합물,
    상기식에서 R6내지 R9은 독립적으로 수소 또는 제1항에서 정의한 치환체 R1이다.
  4. 제3항에 있어서, R6은 저급알콕시이고 R7, R8및 R9가 수소이거나 R6가 저급 알킬옥시 또는 사이클로(저급)알킬(저급)알킬옥시이고 R7이 수소이고, R8이 아미노 또는 저급알킬아미노이며 R9가 할로이거나 R7및 R9가 클로로이며 R6및 R8이 수소인 화합물.
  5. 제1항 내지 제3항중 어느 한 항에 있어서, B가 트로판 3-일인 화합물.
  6. 제1항에 있어서, A가 R1이 수소, 또는 하나의 할로(저급)알킬, 저급알콕시, 저급알킬, 아미노, (저급)알킬아미노, 디(저급)알킬아미노 또는 (저급)알카노일아미노 치환체인 일반식(a) 또는 (b)의 라디칼이거나 Z5가 CH치고 R1이 수소 또는 저급알킬, 저급알콕시, 하이드록시, 할로겐, 할로(저급)알킬, 아미노, 니트로, 카복스아미노(저급)알킬아미노, 디(저급)알킬아미노 및 (저급)알카노일아미노로부터 선택되는 하나 이상의 동일하거나 상이한 치환체인 일반식(c)의 라디칼인 화합물.
  7. 제1항에 있어서, N-(1-아자비사이클로)[2.2.2]옥탄-3-일)-N'-(3,5-디클로로페닐)우레아 또는 약제학적으로 허용되는 이의 염인 화합물.
  8. 제1항에 있어서, N-[[[1-아자비사이클로[2.2.2]옥탄-3-일]아미노]카보닐]-2-메톡시벤즈아미드 또는 약제학적으로 허용되는 이의 염인 화합물.
  9. 제1항에 있어서, N[[[1-아자비사이클르로[2.2.2]옥탄-3-일]아미노]카보닐]-3,5-디클로로벤즈아미드, (엔도)-N-(3,5-디클로로벤조일)-O-(8-메틸-8-아자비사이클로[3.2.1]옥트-3-일)카바메이트 또는 N-(3,5-디클로로페닐)-N'-(1,2-디메틸피라졸리딘-4-일)우레아 또는 약제학적으로 허용되는 이의 염인 화합물.
  10. 제1항에 있어서, N-(아자비사이클로[2.2.2]옥탄-3-일-N'-(3,5-디클로로페닐)티오우레아, (엔도)-N-(3,5-디클로로페닐)-N'(8-메틸-8-아자비사이클로[3.2.1]옥탄-3-일)우레아, N-(1-아자비사이클로[2.2.2]옥탄-3-일)-N'-(3-트리플루오로메틸페닐)우레아, N-(1-아자비사이클로[2.2.2]옥탄-3-일)-N'-(4-클로로페닐)우레아, N-(아자비사이클로[2.2.2]옥탄-3-일)-N'-(1-메틸-1H-인돌-3-일)우레아, N-(아자비사이클로[2.2.2]옥탄-3-일)-N'-(2-벤조티에닐)우레아, (S)-(-)-N-(1-아자비사이클로[2.2.2]옥탄-3-일)-N'-(3,5-디클로로페닐)우레아, (R)-(+)-N-(1-아자비사이클로[2.2.2]옥탄-3-일)-N'-(3,5-디클로로페닐)우레아, N-[[[1-아자비사이클로[2.2.2]옥탄-3-일]아미노]카보닐]-트리플루오로메틸벤즈아미드, N-[[[1-아자비사이클로[2.2.2]옥탄-3-일]아미노]카보닐]-4-메톡시벤즈아미드, N-[[[1-아자비사이클로[2.2.2]옥탄-3-일]아미노]카보닐]나프탈렌-2-카복스아미드 또는 약제학적으로 허용되는 이의 염인 화합물.
  11. 제1항에 있어서, N-[[[1-아자비사이클로[2.2.2]옥탄-3-일]아미노]카보닐]-2-푸란카복스아미드, N-[[[1-아자비사이클로[2.2.2]옥탄-3-일]아미노]카보닐]-2,6-디메틸벤즈아미드, N-[[[1-아자비사이클로[2.2.2]옥탄-3-일]아미노]카보닐]-2-티오펜카복스아미드, N-[[[1-아자비사이클로[2.2.2]옥탄-3-일]아미노]카보닐]-2-플루오로벤즈아미드, N-[[[1-아자비사이클로[2.2.2]옥탄-3-일]아미노]카보닐]-2-에톡시벤즈아미드, N-[[[1-아자비사이클로[2.2.2]옥탄-3-일]아미노]카보닐]-2-이소프로폭시벤즈아미드, 2-알릴옥시-N-[[[1-아자비사이클로[2.2.2]옥탄-3-일]아미노]카보닐]벤즈아미드, N-[[[1-아자비사이클로[2.2.2]옥탄-3-일]아미노]카보닐]-2-피리딘카복스아미드, (엔도)-N-[[[8-메틱-8-아자비사이클로[3.2.1]옥탄-3-일]아미노]카보닐]-2-메톡시벤즈아미드, N-[[[1-아자비사이클로[2.2.2]옥탄-3-일]아미노]카보닐]-2-메틸벤즈아미드, N-[[[1-아자비사이클로[2.2.2]옥탄-3-일]아미노]카보닐]-2-(사이클로프로필)메톡시)벤즈아미드, (S)-N-[[[1-아자비사이클로[2.2.2]옥탄-3-일]아미노]카보닐]-2-메톡시아미드, (R)-N-[[[1-아자비사이클로[2.2.2]옥탄-3-일]아미노]카보닐]-2-메톡시벤즈아미드 또는 (엔도)-O-N-[[[8-메틸-8-아자비사이클로[3.2.1]옥탄-3-일]-N-(3,5디클로로포닐)카바메이트 또는 약제학적으로 허용되는 이의 연인 화합물.
  12. 유효량의 일반식(Ⅰ)의 화합물 또는 약제학적으로 허용되는 이의 산부가염을 편두통, 구토, 불안증, 위장병 또는 정신병 치료를 필요로 하는 온혈동물에게 투여함을 특징으로 하여 상기 질명을 치료하는 방법.
    A-X-NHCW-Y-B (Ⅰ)
    상기식에서 A는
    의 방향족 라디칼 [여기에서, 자유 원자가는 일반식(a)의 융합 환 또는 일반식(b)의 융합환에 결합된다]이고 R1은 수소, 또는 저급알킬, 저급알콕시, 하이드록시, 할로겐, 할로(저급)알킬, 아미노, 니트로, 카복스아미도, 페닐(저급)알킬옥시(여기에서 페닐그룹은 임의로 하나 이상의 저급알킬, 저급알킬옥시 또는 할로치환체에 의해 치환될 수 있다), (저급)알킬아미노, 디(저급)알킬아미노, 디(저급)알킬아미노 및 아실아미노중에서 선택된 하나 이상의 동일하거나 상이한 치환체이고, Z1및 Z2는 CH2-CH, NR2-CH, O-CH, S-CH, CH2-N, O-N, S-N, NR2-N, CH-NR2또는 N-NR2[여기에서 R2는 수소, (저급)알킬, 또는 페닐 또는 페닐 (저급)알킬(여기에서 페닐그룹은 하나 이상의 저급알킬, 저급알킬옥시 또는 할로치환체에 의해 임의로 치환될 수 있다)이다]이고, Z3및 Z4는 CH=CH, O-CH2또는 N=CH이고, Z5는 N 또는 CH이고, Z6는 O, S 또는 NH이고, X는 직접 결합이거나, CO이고, W는 산소 또는 황이고, Y는 NH 또는 산소이고, B는 일반식
    또는 이의 N-옥사이드,
    의 포화 아자사이클릭 환이고, 여기에서 n은 2,3 또는 4이고, m은 1,2 또는 3이고, p는 0,1 또는 2이고, R3은 수소, 또는 (저급)알킬이고, R4및 R5는 각각 수소 또는 저급알킬이며 단, X가 직접결합일 경우, A는 일반식(c) 또는 (d)의 그룹이고 W는 산소이며, 환 (c) 또는 (d)는 -X-NHCW-Y-B 측쇄에 대해 오르토 위치에 치환체를 함유하지 않는다.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019880017218A 1987-12-24 1988-12-22 헤테로사이클릭 화합물 KR970009588B1 (ko)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB8730193 1987-12-24
GB878730193A GB8730193D0 (en) 1987-12-24 1987-12-24 Heterocyclic compounds
JP8730193 1987-12-24
GB8819728 1988-08-19
JP8819728 1988-08-19
GB888819728A GB8819728D0 (en) 1988-08-19 1988-08-19 Heterocyclic compounds

Publications (2)

Publication Number Publication Date
KR890009923A true KR890009923A (ko) 1989-08-04
KR970009588B1 KR970009588B1 (ko) 1997-06-14

Family

ID=26293248

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019880017218A KR970009588B1 (ko) 1987-12-24 1988-12-22 헤테로사이클릭 화합물

Country Status (18)

Country Link
US (2) US4983600A (ko)
EP (2) EP0323077B1 (ko)
JP (1) JP2588265B2 (ko)
KR (1) KR970009588B1 (ko)
AT (2) ATE107304T1 (ko)
AU (1) AU611976B2 (ko)
CA (1) CA1334095C (ko)
DE (2) DE3850255T2 (ko)
DK (2) DK710488A (ko)
ES (2) ES2053959T3 (ko)
FI (1) FI95031C (ko)
GB (1) GB2213816B (ko)
GR (1) GR3002701T3 (ko)
HU (1) HU204267B (ko)
IE (2) IE63474B1 (ko)
IL (1) IL88644A (ko)
PH (1) PH27437A (ko)
PT (1) PT89286B (ko)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK443489D0 (da) * 1989-09-08 1989-09-08 Ferrosan As Substituerede urinstofforbindelser, deres fremstilling og anvendelse
GB8922622D0 (en) * 1989-10-07 1989-11-22 Wyeth John & Brother Ltd Aroylureas
GB2236751B (en) 1989-10-14 1993-04-28 Wyeth John & Brother Ltd Heterocyclic compounds
DK40890D0 (da) * 1990-02-16 1990-02-16 Ferrosan As Substituerede urinstofforbindelser, deres fremstilling og anvendelse
DE4009565A1 (de) * 1990-03-24 1991-09-26 Merck Patent Gmbh Indolderivate
GB9106571D0 (en) * 1991-03-27 1991-05-15 Erba Carlo Spa Derivatives of substituted imidazol-2-one and process for their preparation
US5140023A (en) * 1990-04-27 1992-08-18 G. D. Searle & Co. Azatetracycle compounds
US5223613A (en) * 1990-04-27 1993-06-29 G. D. Searle & Co. Azatetracycle compounds and process of preparing same
JP3122671B2 (ja) * 1990-05-23 2001-01-09 協和醗酵工業株式会社 複素環式化合物
DE69113284T2 (de) * 1990-12-28 1996-02-22 Kyowa Hakko Kogyo Co., Ltd., Tokio/Tokyo Chinolinderivat.
WO1992015585A1 (en) * 1991-03-01 1992-09-17 Pfizer Inc. 1-azabicyclo[3.2.2]nonan-3-amine derivatives
US5196547A (en) * 1991-03-07 1993-03-23 G. D. Searle & Co. Meso-azacyclic amides of imidazopyridine carboxylic acids and analogs thereof
US5137893A (en) * 1991-03-07 1992-08-11 G. D. Searle & Co. Pharmaceutically useful meso-azacyclic amides of imidazopyridine carboxylic acids and analogs thereof
US5260303A (en) * 1991-03-07 1993-11-09 G. D. Searle & Co. Imidazopyridines as serotonergic 5-HT3 antagonists
US5234921A (en) * 1991-03-07 1993-08-10 G. D. Searle & Co. Meso-azacyclic amides of imidazopyridine carboxylic acids and analogs thereof as pharmaceuticals
EP0528026A1 (en) * 1991-03-07 1993-02-24 G.D. Searle & Co. New meso-azacyclic aromatic acid amides and esters as novel serotonergic agents
US5227377A (en) * 1991-03-07 1993-07-13 G. D. Searle & Co. Meso-azacyclic amides of certain bicyclic carboxylic acids
US5219850A (en) * 1991-03-07 1993-06-15 G. D. Searle & Co. Pharmaceutically useful meso-azacyclic amides of imidazopyridine carboxylic acids and analogs thereof
US5516782A (en) * 1991-03-07 1996-05-14 G. D. Searle & Co. New meso-azacyclic aromatic acid amides and esters as novel serotonergic agents
GB9121835D0 (en) * 1991-10-15 1991-11-27 Smithkline Beecham Plc Pharmaceuticals
JPH05310732A (ja) * 1992-03-12 1993-11-22 Mitsubishi Kasei Corp シンノリン−３−カルボン酸誘導体
US5244907A (en) * 1992-03-26 1993-09-14 A. H. Robins Company, Incorporated Carbocyclic carboxylic acid amides and esters of azabicyclic compounds as gastric prokinetic, antiemetic, anxiolytic and antiarrhythmic agents
US5190953A (en) * 1992-03-26 1993-03-02 A. H. Robins Company, Incorporated Heterocyclic carboxylic acid amides and esters of azabicyclic compounds as gastric prokinetic, antiemetic, anxiolytic and antiarrhythmic agents
GB9206989D0 (en) * 1992-03-31 1992-05-13 Glaxo Group Ltd Chemical compounds
WO1993020071A1 (en) * 1992-03-31 1993-10-14 Glaxo Group Limited Substituted phenylcarbamates and phenylureas, their preparation and their use as 5-ht antagonists
GB9217629D0 (en) * 1992-08-19 1992-09-30 Wyeth John & Brother Ltd Aroylureas
GB2269747B (en) * 1992-08-19 1996-06-05 Wyeth John & Brother Ltd Aroyl-ureas as pharmaceuticals, particularly 5-ht3 antagonists
GB9224144D0 (en) * 1992-11-18 1993-01-06 Erba Carlo Spa Phenyl-imidazolidinone derivatives and process for their preparation
GB9314174D0 (en) * 1993-07-08 1993-08-18 American Home Prod 5-ht3-antagonists
US6676925B1 (en) * 1996-03-20 2004-01-13 Wake Forest University Sigma-2 receptors as biomarkers of tumor cell proliferation
JP2000506896A (ja) * 1996-03-20 2000-06-06 ウェイク フォレスト ユニバーシティ 腫瘍細胞増殖のバイオマーカーとしてのシグマ―２レセプター
US6022884A (en) 1997-11-07 2000-02-08 Amgen Inc. Substituted pyridine compounds and methods of use
WO2001080905A2 (en) 2000-04-27 2001-11-01 Wake Forest University Health Sciences Sigma-2 receptors as biomarkers of tumor cell proliferation
US6492385B2 (en) 2000-08-18 2002-12-10 Pharmacia & Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease
JP2004506735A (ja) 2000-08-18 2004-03-04 ファルマシア・アンド・アップジョン・カンパニー 疾患治療用キヌクリジン置換アリール化合物
AU2001282873A1 (en) 2000-08-18 2002-03-04 Pharmacia And Upjohn Company Quinuclidine-substituted aryl compounds for treatment of disease
WO2002017358A2 (en) 2000-08-21 2002-02-28 Pharmacia & Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic acetylcholine receptor antagonists)
WO2002015662A2 (en) 2000-08-21 2002-02-28 Pharmacia & Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic acetylcholine receptor antagonists
PE20021019A1 (es) 2001-04-19 2002-11-13 Upjohn Co Grupos azabiciclicos sustituidos
AR036040A1 (es) 2001-06-12 2004-08-04 Upjohn Co Compuestos de heteroarilo multiciclicos sustituidos con quinuclidinas y composiciones farmaceuticas que los contienen
AR036041A1 (es) * 2001-06-12 2004-08-04 Upjohn Co Compuestos aromaticos heterociclicos sustituidos con quinuclidina y composiciones farmaceuticas que los contienen
EP1419161A1 (en) 2001-08-24 2004-05-19 PHARMACIA &amp; UPJOHN COMPANY Substituted-heteroaryl-7-aza 2.2.1]bicycloheptanes for the treatment of disease
JP2005504059A (ja) * 2001-08-24 2005-02-10 ファルマシア アンド アップジョン カンパニー リミティド ライアビリティー カンパニー 疾患を処置するための置換アリール７−アザ［２．２．１］ビシクロヘプタン
EP1425286B1 (en) * 2001-09-12 2007-02-28 Pharmacia & Upjohn Company LLC Substituted 7-aza-[2.2.1]bicycloheptanes for the treatment of diseases
IL160884A0 (en) 2001-10-02 2004-08-31 Upjohn Co Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
MXPA04003986A (es) * 2001-10-26 2004-07-23 Upjohn Co Carboxamidas hetero-biciclicas n-azabiciclico sustituidas como agonistas nachr.
US6849620B2 (en) 2001-10-26 2005-02-01 Pfizer Inc N-(azabicyclo moieties)-substituted hetero-bicyclic aromatic compounds for the treatment of disease
MXPA04004464A (es) * 2001-11-08 2004-08-11 Upjohn Co Compuestos de heteroarilo sustituido con azabiciclo para el tratamiento de enfermedades.
BR0214016A (pt) 2001-11-09 2004-10-13 Upjohn Co Compostos azabicìclico-fenil-fundido heterocìclicos e seu uso como ligandos alfa 7 nachr
JP2005522456A (ja) 2002-02-15 2005-07-28 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー Ｃｎｓ関連障害治療のためのアザビシクロ置換ベンゾイルアミドおよびチオアミド
JP2005523288A (ja) * 2002-02-19 2005-08-04 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 疾病治療用の縮合した二環式−ｎ−架橋−複素環式芳香族カルボキサミド
MXPA04008152A (es) * 2002-02-19 2005-09-08 Upjohn Co Compuestos azabiciclicos para el tratamiento de enfermedades.
EP1478646A1 (en) * 2002-02-20 2004-11-24 PHARMACIA &amp; UPJOHN COMPANY Azabicyclic compounds with alfa7 nicotinic acetylcholine receptor activity
JP2005537297A (ja) * 2002-08-01 2005-12-08 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー アルファ−７ｎａｃｈｒ活性を有する１ｈ−ピラゾールおよび１ｈ−ピロール−アザビシクロ化合物
BR0315056A (pt) * 2002-11-01 2005-08-16 Pharmacia & Upjohn Co Llc Compostos tendo tanto atividade agonista nicotìnica de alfa7 quanto atividade antagonista de 5ht3 para o tratamento de doenças do sistema nervoso central
JPWO2005099698A1 (ja) * 2004-04-15 2008-03-06 エーザイ・アール・アンド・ディー・マネジメント株式会社 安定化された４−アミノ−５−クロロ−Ｎ−［（１Ｒ，３ｒ，５Ｓ）−８−メチル−８−アザビシクロ［３．２．１］オクタ−３−イル］−２−［１−メチルブタ−２−インイルオキシ］ベンズアミド含有組成物
PT2685986T (pt) 2011-03-18 2020-03-05 Genzyme Corp Inibidor de glicosilceramida-sintase
JOP20130273B1 (ar) 2012-09-11 2021-08-17 Genzyme Corp مثبطات انزيم (سينثاز) غلوكوسيل سيراميد
EP4185267A1 (en) 2020-07-24 2023-05-31 Genzyme Corporation Pharmaceutical compositions comprising venglustat

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4207327A (en) * 1977-08-19 1980-06-10 A. H. Robins Company, Inc. N-(4-Pyrazolidinyl)benzamides and their amino precursors
EP0099194A3 (en) * 1982-07-03 1984-04-11 Beecham Group Plc Novel benzamides
EP0158265A2 (en) * 1984-04-13 1985-10-16 Beecham Group Plc Benzamide and anilide derivatives
CA1260474A (en) * 1984-12-03 1989-09-26 Raymond A. Stokbroekx Benzoxazol- and benzothiazolamine derivatives
EP0200444B1 (en) * 1985-04-27 1992-11-11 Beecham Group Plc Azabicyclononyl-indazole-carboxamide having 5-ht antagonist activity
GB8525913D0 (en) * 1985-10-21 1985-11-27 Beecham Group Plc Compounds
GB8520616D0 (en) * 1985-08-16 1985-09-25 Beecham Group Plc Compounds
GB8525844D0 (en) * 1985-10-19 1985-11-20 Beecham Group Plc Compounds
EP0235878A3 (en) * 1986-01-16 1989-06-14 Beecham Group Plc Novel compounds
DE3785507T2 (de) * 1986-07-31 1993-07-29 Beecham Group Plc Azabicyclische verbindungen, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung.

Also Published As

Publication number Publication date
ES2051867T3 (es) 1994-07-01
EP0323077B1 (en) 1991-09-11
AU2670288A (en) 1989-06-29
FI95031B (fi) 1995-08-31
DK82793D0 (da) 1993-07-08
EP0361629B1 (en) 1994-06-15
IE883661L (en) 1989-05-24
DK82793A (da) 1993-07-08
GB8829164D0 (en) 1989-01-25
CA1334095C (en) 1995-01-24
KR970009588B1 (ko) 1997-06-14
IL88644A0 (en) 1989-07-31
US5106843A (en) 1992-04-21
DK710488A (da) 1989-06-25
HU204267B (en) 1991-12-30
DE3850255D1 (de) 1994-07-21
DE3864807D1 (de) 1991-10-17
FI95031C (fi) 1995-12-11
PT89286A (pt) 1989-12-29
US4983600A (en) 1991-01-08
ES2053959T3 (es) 1994-08-01
EP0361629A2 (en) 1990-04-04
IE881029L (en) 1989-06-24
IL88644A (en) 1993-05-13
DE3850255T2 (de) 1994-09-22
EP0361629A3 (en) 1990-06-13
FI885917A (fi) 1989-06-25
AU611976B2 (en) 1991-06-27
JPH01203365A (ja) 1989-08-16
GB2213816A (en) 1989-08-23
IE63474B1 (en) 1995-04-19
GB2213816B (en) 1991-05-08
ATE67200T1 (de) 1991-09-15
IE62231B1 (en) 1995-01-11
PH27437A (en) 1993-07-02
HUT53101A (en) 1990-09-28
DK710488D0 (da) 1988-12-20
PT89286B (pt) 1994-11-30
ATE107304T1 (de) 1994-07-15
JP2588265B2 (ja) 1997-03-05
GR3002701T3 (en) 1993-01-25
EP0323077A1 (en) 1989-07-05

Similar Documents

Publication Publication Date Title
KR890009923A (ko) 헤테로사이클릭 화합물
KR890012649A (ko) 아릴아미도(및 아릴티오아미도)-아자비사이클로 알칸으로 기억력을 향상시키거나 기억력 부족을 교정시키는 방법
NO884202L (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzimidazolin-2-okso-1-karboksylsyrederivater.
FI893467A0 (fi) Menetelmä lääkeaineena käyttökelpoisten 4-oksokinoliini-3-karboksyylihapon johdannaisten valmistamiseksi
HK1008918A1 (en) N-substituted heterocycle derivatives their preparation compositions containing them
EP1310494A4 (en) PPAR-DELTA ACTIVATORS
PT93066A (pt) Processo para a preparacao de derivados heterociclicos contendo nucleos bengenicos fundidos com nucleos monoazotados substituidos e de composicoes farmaceuticas que os contem
DE69205327D1 (de) Harnstoffderivate, Verfahren zu ihrer Herstellung und diese enthaltende Medikamente.
GB1046506A (en) Guanidine compounds and process for their manufacture
MY103837A (en) Thiazolidinedione derivatives as hypoglycemic agents.
GB1273412A (en) Control of pests with cycloalkane derivatives of nitrated aryl compounds
FI98372B (fi) Menetelmä farmaseuttisesti käyttökelpoisten -D-fenyylitioksylosidien valmistamiseksi
KR910006292A (ko) 방향족 산의 n-아자비시클로 [3.3.0] 옥탄 아미드
GB1348558A (en) Meta-bis-anilide derivatives and their use as herbicides

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20011023

Year of fee payment: 5

LAPS Lapse due to unpaid annual fee